News
$Pulse Biosciences (PLSE.US)$ Reuters · just 1min. Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for Cellfx® Nspfa Cardiac Surgery System for the Treatment of Atrial Fibrillation
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
